Colistin–tigecycline versus colistin–imipenem–cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study

Intensive Care Medicine

Volumn 41, Issue 11, 2015, Pages 2018-2019

  Chaari, Anis ^a   Pham, Tài ^b,c,d   Mnif, Basma ^a   Chtara, Kamilia ^a   Medhioub, Fatma ^a   Baccouche, Najeh ^a   Bahloul, Mabrouk ^a   Hammami, Adnène ^a   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c PARIS DESCARTES UNIVERSITY   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN; COLISTIN; IMIPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; CILASTATIN, IMIPENEM DRUG COMBINATION; DRUG COMBINATION; MINOCYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; COMBINATION CHEMOTHERAPY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MORTALITY; MULTIDRUG RESISTANCE; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECTS; EPIDEMIOLOGY; MICROBIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL ANALYSIS; TUNISIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CILASTATIN; COLISTIN; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; MINOCYCLINE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TUNISIA;

EID: 84942505201     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-4010-z     Document Type: Letter

References (5)

1. Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41(5):776–795
2. Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA (2007) In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51(5):1621–1626
3. Freire AT, Melnyk V, Kim MJ, Datsenko O, Dzyublik O, Glumcher F, Chuang YC, Maroko RT, Dukart G, Cooper CA et al (2010) Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiol Infect Dis 68(2):140–151
4. Burkhardt O, Rauch K, Kaever V, Hadem J, Kielstein JT, Welte T (2009) Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint. Int J Antimicrob Agents 34(1):101–102
5. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A et al (2009) Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 53(8):3430–3436